491 related articles for article (PubMed ID: 8315518)
1. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.
Stier CT; Adler LA; Levine S; Chander PN
J Hypertens Suppl; 1993 Apr; 11(3):S37-42. PubMed ID: 8315518
[TBL] [Abstract][Full Text] [Related]
2. The antiproteinuric action of enalapril in stroke-prone spontaneously hypertensive rats is unrelated to alterations in urinary prostaglandins.
Stier CT; Mahboubi K; DiPippo VA; Levine S; Chander PN
J Pharmacol Exp Ther; 1992 Mar; 260(3):1410-5. PubMed ID: 1545401
[TBL] [Abstract][Full Text] [Related]
3. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
Niederberger M; Aubert JF; Nussberger J; Brunner HR; Waeber B
J Hypertens; 1995 Apr; 13(4):439-45. PubMed ID: 7629405
[TBL] [Abstract][Full Text] [Related]
4. Prevention of stroke with perindopril treatment in stroke-prone spontaneously hypertensive rats.
Wang H; Delaney KH; Kwiecien JM; Smeda JS; Lee RM
Clin Invest Med; 1997 Oct; 20(5):327-38. PubMed ID: 9336658
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats.
von Lutterotti N; Camargo MJ; Campbell WG; Mueller FB; Timmermans PB; Sealey JE; Laragh JH
J Hypertens; 1992 Sep; 10(9):949-57. PubMed ID: 1328376
[TBL] [Abstract][Full Text] [Related]
6. Discovery of losartan, the first angiotensin II receptor antagonist.
Timmermans PB; Duncia JV; Carini DJ; Chiu AT; Wong PC; Wexler RR; Smith RD
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
Nagura J; Yamamoto M; Hui C; Yasuda S; Hachisu M; Konno F
Clin Exp Pharmacol Physiol; 1996 Mar; 23(3):229-35. PubMed ID: 8934613
[TBL] [Abstract][Full Text] [Related]
8. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II.
Gahnem F; Camargo MJ; von Lutterotti N; Laragh JH; Sealey JE
J Hypertens; 1995 Jan; 13(1):91-6. PubMed ID: 7759857
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
Dahlöf B
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 2nd communication: valsartan prevents end-organ damage in spontaneously hypertensive stroke-prone rats during 1-year treatment.
Kometani M; Hayashi N; Yamamoto S; Nakao K; Inukai T
Arzneimittelforschung; 1997 May; 47(5):613-9. PubMed ID: 9205774
[TBL] [Abstract][Full Text] [Related]
11. The future role of losartan.
Hansson L
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S55-8. PubMed ID: 8583483
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.
Pollock DM; Divish BJ; Polakowski JS; Opgenorth TJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):657-63. PubMed ID: 8246138
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Fu LP; Obara K; Saito T; Abe K
J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858
[TBL] [Abstract][Full Text] [Related]
14. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade.
Camargo MJ; von Lutterotti N; Campbell WG; Pecker MS; James GD; Timmermans PB; Laragh JH
J Hypertens; 1993 Jan; 11(1):31-40. PubMed ID: 8382237
[TBL] [Abstract][Full Text] [Related]
15. Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study.
Nielsen S; Dollerup J; Nielsen B; Jensen HA; Mogensen CE
Nephrol Dial Transplant; 1997; 12 Suppl 2():19-23. PubMed ID: 9269694
[TBL] [Abstract][Full Text] [Related]
16. ME3221, a surmountable angiotensin AT1-receptor antagonist, prevents hypertensive complications in aged stroke-prone spontaneously hypertensive rats.
Nagura J; Hui C; Yamamoto M; Yasuda S; Abe M; Hachisu M; Konno F
Jpn J Pharmacol; 1996 May; 71(1):39-49. PubMed ID: 8791170
[TBL] [Abstract][Full Text] [Related]
17. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
18. A new class of therapeutic agents: the angiotensin II receptor antagonists.
Timmermans PB; Smith RD
Cardiologia; 1994 Dec; 39(12 Suppl 1):397-400. PubMed ID: 7634303
[TBL] [Abstract][Full Text] [Related]
19. [Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy].
Krasnikova TL
Klin Med (Mosk); 1996; 74(3):17-21. PubMed ID: 8926692
[No Abstract] [Full Text] [Related]
20. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats.
Soltis EE
J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
